Jae-Won Shin

Title: Jae-Won Shin: Innovator in Bioreactor Technology

Introduction

Jae-Won Shin is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of bioreactor technology, particularly in the isolation of rare blood cells. His innovative approach has the potential to impact medical research and treatment.

Latest Patents

Jae-Won Shin holds a patent for a bioreactor designed for the isolation of rare cells, including hematopoietic stem cells and megakaryocytes. The patent, titled "Bioreactor for isolation of rare cells and methods of use," describes an apparatus that incorporates a soft substrate and an anti-contractility agent. This design creates a soft microenvironment conducive to the survival of non-dividing cells while effectively eliminating dividing cells. This unique property allows for the straightforward isolation of rare blood cells without the need for expensive equipment and antibodies. He has 1 patent to his name.

Career Highlights

Jae-Won Shin is affiliated with the University of Pennsylvania, where he continues to advance his research and innovations. His work has garnered attention for its practical applications in the medical field, particularly in regenerative medicine and cell therapy.

Collaborations

One of his notable collaborators is Dennis E Discher, with whom he has worked on various research projects. Their combined expertise has contributed to advancements in bioreactor technology and cell isolation methods.

Conclusion

Jae-Won Shin is a key figure in the development of bioreactor technology for the isolation of rare blood cells. His innovative patent and ongoing research at the University of Pennsylvania highlight his commitment to advancing medical science.